M. Moriarty

2.9k total citations
60 papers, 1.8k citations indexed

About

M. Moriarty is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, M. Moriarty has authored 60 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 14 papers in Surgery and 14 papers in Molecular Biology. Recurrent topics in M. Moriarty's work include Management of metastatic bone disease (7 papers), Advanced Radiotherapy Techniques (6 papers) and Pancreatic and Hepatic Oncology Research (6 papers). M. Moriarty is often cited by papers focused on Management of metastatic bone disease (7 papers), Advanced Radiotherapy Techniques (6 papers) and Pancreatic and Hepatic Oncology Research (6 papers). M. Moriarty collaborates with scholars based in Ireland, United States and United Kingdom. M. Moriarty's co-authors include Anne White, D. Fennelly, John Hyland, David Gibbons, Hugh Mulcahy, Diarmuid P. O’Donoghue, Darren Treanor, Kieran Sheahan, Ronan Ryan and Martin Clynes and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Molecular Sciences and British Journal of Cancer.

In The Last Decade

M. Moriarty

58 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Moriarty Ireland 18 815 552 467 456 244 60 1.8k
Nadine Houédé France 26 767 0.9× 908 1.6× 733 1.6× 484 1.1× 156 0.6× 136 2.5k
Graeme J. Poston United Kingdom 20 1.6k 1.9× 637 1.2× 627 1.3× 271 0.6× 224 0.9× 45 2.5k
Peter Canney United Kingdom 25 1.3k 1.5× 336 0.6× 472 1.0× 359 0.8× 397 1.6× 77 2.6k
Mitsue Saito Japan 20 738 0.9× 504 0.9× 342 0.7× 336 0.7× 112 0.5× 119 1.7k
Dario Giuffrida Italy 30 1.0k 1.3× 1.1k 2.1× 475 1.0× 818 1.8× 203 0.8× 94 3.6k
Susan A. Higgins United States 22 863 1.1× 431 0.8× 362 0.8× 336 0.7× 217 0.9× 58 2.1k
Sophie Gourgou France 28 1.1k 1.4× 745 1.3× 812 1.7× 358 0.8× 436 1.8× 123 2.3k
Peter Whelan United Kingdom 25 458 0.6× 650 1.2× 1.5k 3.1× 355 0.8× 172 0.7× 87 2.5k
Jean Trédaniel France 26 1.2k 1.5× 428 0.8× 974 2.1× 565 1.2× 288 1.2× 109 2.6k
Caio Rocha‐Lima United States 20 1.0k 1.2× 217 0.4× 482 1.0× 521 1.1× 199 0.8× 57 1.6k

Countries citing papers authored by M. Moriarty

Since Specialization
Citations

This map shows the geographic impact of M. Moriarty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Moriarty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Moriarty more than expected).

Fields of papers citing papers by M. Moriarty

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Moriarty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Moriarty. The network helps show where M. Moriarty may publish in the future.

Co-authorship network of co-authors of M. Moriarty

This figure shows the co-authorship network connecting the top 25 collaborators of M. Moriarty. A scholar is included among the top collaborators of M. Moriarty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Moriarty. M. Moriarty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Dunne, Mary, Orla McArdle, Cormac Small, et al.. (2022). Efficacy and toxicity of primary re-irradiation for malignant spinal cord compression based on radiobiological modelling: a phase II clinical trial. British Journal of Cancer. 128(4). 576–585. 2 indexed citations
3.
Thirion, P., Mary Dunne, Imelda Parker, et al.. (2020). CTRIAL-IE (ICORG) 07-11: Phase II Trial Evaluating Radiobiological Based Reirradiation Strategy for Patients with Malignant Spinal Cord Compression. International Journal of Radiation Oncology*Biology*Physics. 108(3). S33–S34. 2 indexed citations
4.
Bonanni, Laura, Megan Greally, Donal Maguire, et al.. (2019). neoadjuvant therapy for borderline resectable pancreatic ductal adenocarcinoma (PDA) involving a high volume pancreatic centre in Ireland. HPB. 21. S976–S976. 1 indexed citations
5.
Moriarty, M., et al.. (2018). Fishing in the Dark: Retrieving BrokenInstruments during a Spinal Lumbar Discectomy. 2(2). 1–4. 1 indexed citations
6.
Dowling, Paul, Annemarie Larkin, Michael Henry, et al.. (2014). Abnormal levels of heterogeneous nuclear ribonucleoprotein A2B1 (hnRNPA2B1) in tumour tissue and blood samples from patients diagnosed with lung cancer. Molecular BioSystems. 11(3). 743–752. 26 indexed citations
7.
Clarke, Colin, Stephen F. Madden, Padraig Doolan, et al.. (2013). Correlating transcriptional networks to breast cancer survival: a large-scale coexpression analysis. Carcinogenesis. 34(10). 2300–2308. 294 indexed citations
8.
Moriarty, M.. (2012). A Comparison of United States and Foreign Condominiums. St. John's law review. 48(4). 19. 4 indexed citations
9.
Burke, John P., Donal Maguire, Joseph S. Dillon, M. Moriarty, & Gary O’Toole. (2009). Whipple’s procedure for an oligometastasis to the pancreas from a leiomyosarcoma of the thigh. Irish Journal of Medical Science (1971 -). 181(3). 361–363. 6 indexed citations
10.
Condron, Claire, et al.. (2009). Taurine attenuates radiation-induced lung fibrosis in C57/Bl6 fibrosis prone mice. Irish Journal of Medical Science (1971 -). 179(1). 99–105. 18 indexed citations
11.
Beddy, David, John Hyland, D. C. Winter, et al.. (2008). A Simplified Tumor Regression Grade Correlates with Survival in Locally Advanced Rectal Carcinoma Treated with Neoadjuvant Chemoradiotherapy. Annals of Surgical Oncology. 15(12). 3471–3477. 116 indexed citations
12.
Dowling, Paul, Lorraine O’Driscoll, Paula Meleady, et al.. (2007). 2‐D difference gel electrophoresis of the lung squamous cell carcinoma versus normal sera demonstrates consistent alterations in the levels of ten specific proteins. Electrophoresis. 28(23). 4302–4310. 63 indexed citations
13.
Ryan, Ronan, David Gibbons, John Hyland, et al.. (2005). Pathological response following long‐course neoadjuvant chemoradiotherapy for locally advanced rectal cancer. Histopathology. 47(2). 141–146. 497 indexed citations
14.
Thirion, P., et al.. (2004). Escalated dose for non-small-cell lung cancer with accelerated hypofractionated three-dimensional conformal radiation therapy. Radiotherapy and Oncology. 71(2). 163–166. 49 indexed citations
15.
Waldron, Dympna, Ciaran A. O’Boyle, Michael Kearney, M. Moriarty, & Desmond N. Carney. (1999). Quality-of-Life Measurement in Advanced Cancer: Assessing the Individual. Journal of Clinical Oncology. 17(11). 3603–3611. 156 indexed citations
16.
Heenan, Mary, et al.. (1996). Absence of correlation between chemo- and radioresistance in a range of human tumour cell lines. Cytotechnology. 19(3). 237–242. 8 indexed citations
17.
Domrongkitchaiporn, Somnuek, et al.. (1994). The Influence of Continuous Ambulatory Peritoneal Dialysis Connection Technique on Peritonitis Rate and Technique Survival. American Journal of Kidney Diseases. 24(1). 50–58. 5 indexed citations
18.
Moriarty, M., et al.. (1993). Clinical significance of cellular resistance in tumours to cytotoxic chemotherapy and radiotherapy. Cytotechnology. 12(1-3). 385–391. 4 indexed citations
19.
Soden, Muriel, Jaythoon Hassan, David L. Scott, et al.. (1989). Lymphoid irradiation in intractable rheumatoid arthritis. Long‐term followup of patients treated with 750 rads or 2,000 rads. Arthritis & Rheumatism. 32(5). 523–530. 15 indexed citations
20.
Mothersill, Carmel, et al.. (1986). Radiation survival and transformation in differentiated human cells in culture.. Europe PMC (PubMed Central). 7. 251–252. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026